Broncus Medical

Broncus Medical is a medical technology company based in Mountain View, California, specializing in the development of minimally invasive devices for lung diseases, particularly emphysema. The company is focused on its Exhale product line, which includes the innovative Airway Bypass treatment, aimed at addressing homogeneous emphysema, a condition affecting a significant portion of patients with the disease. Broncus is currently conducting the pivotal EASE Trial to evaluate this treatment in patients with severe homogeneous emphysema. Additionally, the company offers a range of interventional pulmonology products designed to enhance the diagnosis and treatment of lung conditions, including lung cancer and chronic obstructive pulmonary disease (COPD). Broncus operates globally, with a significant presence in China and an international office in Nyon, Switzerland.

Thomas Keast

Vice President of Product Development and Operations

1 past transactions

Uptake Medical

Acquisition in 2016
Uptake Medical develops innovative medical technologies for the treatment of lung diseases. Its first product, InterVapor™, is the first and only approach to endoscopic lung volume reduction for people with severe emphysema that uses the body’s natural healing process without leaving any foreign materials in the lung. In clinical studies, InterVapor has demonstrated clinically meaningful improvements in breathing function, exercise capacity and quality of life.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.